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ABSTRACT
Objectives: Recurrent reproductive loss (RPL) is a global health issue affecting a significant number of women. Approxi-
mately half of miscarriages have an unexplained etiology. Familial aggregation and twins studies prove that some cases of 
the RPL could have a genetic background. Recent evidences suggest that cytokines (e.g. IL-6, TNF alpha or TGF beta) and 
matrix metalloproteinases (MMP) are important for maintenance of pregnancy. Single gene polymorphisms (SNP), affect-
ing these proteins production or their function may predispose to the loss of the pregnancy. The aim of this study was to 
evaluate the association between the following polymorphisms of IL6 (rs1800795), TNF (rs1800629), TGFB1 (rs1800471), 
MMP1 (rs1799750), MMP2 (rs2285053 and rs243865), MMP3 (rs35068180), MMP9 (rs3918242) and the recurrent pregnancy 
loss in polish population. 
Material and methods: Study subjects comprised of 67 patients with a history of recurrent pregnancy loss (≥ 2 miscar-
riages in history) and 75 controls. The distribution of genotypes for selected polymorphisms were determined by RFLP-PCR. 
Results: Maternal genotypes GG TNF, or 5A/5A MMP3 may be associated with the recurrent pregnancy loss. No association 
between the IL6, TGFB1, MMP1, MMP2, or MMP9 studied polymorphisms and the predisposition to miscarriage was found. 
Conclusions: This study demonstrated a possible association between rs1800629 TNF, rs35068180 MMP3 polymorphisms 
and recurrent pregnancy loss.
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INTRODUCTION
Recurrent pregnancy loss (RPL) is a reproductive disor-
der, which affects approximately 1–5% of couples [1, 2]. Mis-
carriages occur in 10–15% and even up to 30% of pregnan-
cies [3, 4]. Repeatability of recurrent reproductive wastage in 
a certain number of couples shows that the phenomenon is 
not random and urges to define a cause. Genetic variation 
may have a high impact on reproductive failure and thus 
delineating of specific genetic factors is of great importance 
for genetic counselling. 
RPL is traditionally defined as the occurrence of three or 
more (≥ 3) consecutive pregnancy losses before 20 weeks 
of gestation. However, due to the growing problem of in-
fertility, global and European scientific societies including 
the American Society of Reproductive Medicine (ASRM) and 
European Society of Human Reproduction (ESRE), has re-
cently redefined RPL as two or more pregnancy losses [5, 6]. 
The aetiology of the disease comprises of different fac-
tors, such as autoimmune diseases (20%), endocrinological 
disorders (17–20%), uterine alterations (10–15%), genetic 
factors such as chromosome abnormalities in the parents 
(2–5%) and infections (0.5–5%) [7]. Nevertheless, approxi-
mately 50% of RPL cases remain unexplained and defined 
as idiopathic [3, 4]. 
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Familial predisposition to RPL is described [8, 9]. Clinical 
data suggest from two to sevenfold increased prevalence 
of RPL among first-degree blood relatives compared to the 
general population [9]. Population-based register studies 
showed that overall frequency of miscarriage among the 
siblings of idiopathic RPL is approximately doubled com-
pared to general population [10, 11]. A genome-wide link-
age scan using sibling pairs with idiopathic RPL confirmed 
heterogeneity of contributing genetic factors [11, 12]. More-
over, some studies emphasize that not only maternally, but 
also paternally inherited genetic factors might influence the 
miscarriages [12–14]. 
A successful pregnancy is the result of a number of 
processes including implantation, decidual tissue and ves-
sel remodeling and maternal-fetus immune tolerance [15]. 
Each of these phenomena may be genetically determined. 
Recent research results show that cytokines and extracel-
lular matrix metalloproteinases (MMPs) are important de-
terminants of the opening of the implantation window and 
the proper invasion of trophoblast into the uterine wall and 
maintenance of pregnancy [16–19]. 
The maintenance of pregnancy depends on the bal-
ance between Th1 and Th2 cells [20]. It was proven that 
domination of the anti-inflammatory Th2 cytokine pattern 
is associated with gestational success/normal pregnancy, 
whereas a pro-inflammatory Th1 cytokine profile is related 
to the pregnancy failure [20]. 
Communication between trophoblastic and decidual 
cells is mediated by cytokines e.g. IL6, TNFa, TGFb [21]. 
The cytokines production undergo the genetic control, and 
the genetic polymorphisms might influence the modulation 
of their expression therefore it may be at least partially re-
sponsible for the incidence of unexplained recurrent preg-
nancy losses [22]. 
Metalloproteinases belong to a large family of zinc-de-
pendent endopeptidases that include collagenases (MMP1, 
MMP8, and MMP13), gelatinases (MMP2, MMP9), strome-
lysins (MMP3, MMP10), matrilysins (MMP7, MMP26), and 
transmembrane metalloproteinases types I and II. MMPs are 
crucial regulators of vascular and uterine remodeling and 
are involved in spiral artery formation and adhesion [23]. 
Changes in the nucleotide sequences in the binding 
sites of transcription factors or transcription repressors alter 
the regulation of MMP gene expression and the level of their 
protein products. The imbalance in the MMPs level disurbes 
the process of implantation and placenation [24]. 
Objectives
The aim of this study is to evaluate the association 
between the following polymorphisms: rs1800795 (IL6 
gene), rs1800629 (TNF gene), rs1800471 (TGFB1 gene), 
rs1799750 (MMP1 gene), rs2285053 and rs243865 (MMP2 
gene), rs35068180 (MMP3 gene), rs3918242 (MMP9 gene) 
and the recurrent pregnancy loss in case and control groups. 
MATERIAL AND METHODS
Blood samples were collected from 67 women with 
a history of two or more consecutive spontaneous abortions 
(mean age of 32.85 ± 5.53 years old) and 75 healthy women 
who had a history of successful pregnancy (mean age of 
35.11 ± 3.98 years old). Case groups were enrolled between 
September 2016 and June 2018 in Department of Genetics, 
Polish Mother’s Memorial Hospital Research Institute in Łódź 
and Department of Obstetrics and Perinatology, Jagiello-
nian Medical University of Cracow, Poland. 
All members of the study and control groups were 
Caucasians and residents of Poland, with no immunologi-
cal diseases, weight disorders [obesity body mass index 
(BMI) < 30 kg/m2], hypertension, diabetes or coagulation 
disorders.
The study was positively evaluated by the Bioethics 
Committee at the Polish Mother’s Memorial Hospital Re-
search Institute in Łódź. All participants were informed of 
the study protocol and completed a consent form before 
participating to the study. 
DNA extraction
Peripheral venous blood samples (3–5 mL) from patients 
with RPL and controls were collected into EDTA-coated 
vacutainers. Genomic DNA was isolated from peripheral 
blood leukocytes by standard procedures using a com-
mercially available kits Blood Mini Kit and Genomic Midi AX 
(A&A Biotechnology, Poland). The concentration and quality 
of the DNA were examined by optical density in a spectro-
photometer NanoDrop 2000 (ThermoFisher Scientific, USA).
Genotyping
The above-mentioned polymorphic variants were geno-
typed by polymerase chain reaction — restriction fragment 
length polymorphism (PCR-RFLP). PCR reaction conditions 
was optimized for each polymorphism. Characteristic of 
the polymorphisms and the specific primer sequences are 
shown in Table 1. 
Statistical Analyses 
Data analysis was performed using Statistica v12 (Stat-
Soft, Tulsa, OK). The Hardy–Weinberg equilibrium was 
tested in control group. Comparisons of variables with 
a categorizing distribution were made using the chi2 test 
or the Yates corrected chi2 test or the Fisher bilateral test. 
Variables relevant for single-factor comparisons were in-
troduced to the regression model. To multifactor analysis 
(logistic regression) those parameters were introduced, 
which in univariate analyses obtained the significance 
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level p < 0.15. Multivariate analysis was performed with 
backward stepwise logistic regression. Results for which 
p was < 0.05 were considered statistically significant. 
For allele carriers and genotypes whose frequencies dif-
fered between groups, the odds ratio (OR) was calculated 
with a 95% confidence interval (CI). 
RESULTS
The distribution of genotypes and alleles for the eight in-
vestigated polymorphisms and deviation from Hardy–Wein-
berg equilibrium in RPL cases and in control group are 
shown in Table 2. 
Among the 8 polymorphisms, only 3: rs1800629 (TNF 
gene), rs243865 (MMP2 gene) and rs35068180 (MMP3 gene) 
demonstrated a significant association with risk of recur-
rent pregnancy loss. Significant statistically relevant mater-
nal genotypes were included in the multivariable analysis. 
The results of this analysis are presented in Table 3. 
These analyses revealed that GG homozygosity in 
TNF rs1800629 increases over 2.5 times the risk of RPL 
(OR = 2.56, 95% CI: 1.23–5.32; p = 0,0002). We also observed 
MMP3 rs35068180 homozygosity 5A/5A decreases the risk 
of RPL 0.24-fold (OR = 0.24, 95% CI: 0.11–0.52). 
Based on univariate analysis, the statistical significance 
of the data for the analysis of the rs243865 polymorphic 
variant of the MMP2 gene was not confirmed. 
No associations between occurrence of recurrent preg-
nancy loss and the distribution of genotypes or alleles of 
studied IL6, TGFB1, MMP1, MMP9 and MMP2 rs2285053 gene 
polymorphisms were observed. 
DISCUSSION
The regulation of cytokine and metalloproteinase secre-
tion in the maternal-fetal interface plays a pivotal role in the 
process of trophoblast invasion and placentation. 
The present study examines whether the occurrence 
of eight single-nucleotide polymorphisms (SNPs) in the 
IL6, TNF, TGFB1, MMP1, MMP2, MMP3 and MMP9 genes 
is related to the recurrent pregnancy loss. We observed 
that the three following polymorphisms: TNF rs1800629, 
MMP2 rs243865 and MMP3 rs35068180 are associated with 
the recurrent pregnancy loss.
Tumor necrosis factor α (TNF alpha) is a cytokine associ-
ated with the regulation of a wide spectrum of biological 
processes, including inflammation, cell proliferation and 
apoptosis. This multifunctional proinflammatory cytokine is 
produced mainly by the active monocytes and macrophages 
and by other cells (adipocytes, keratinocytes, fibroblasts, 
neutrophils, mast cells and some lymphocytes). 
The TNF gene is located on chromosome 6p21.33. Chang-
es in the nucleotide sequence of the gene in its promoter 
part are very important because the expression of the TNF 
Table 1. Primer sequences, annealing temperatures, and restriction enzymes of the polymorphisms

























IL6 rs1800795 -174G>C F: GTCAAGACATGCCAAAGTGCTR: GAGGGGCTGATTGGAAACC 60°C NlaIII
GG-173, 11
GC-173, 122, 51, 11
CC-122, 51, 11




TGFB1 rs1800471 915C>G Arg25Pro
F: CACACCAGCCCTGTTCGC
R: CTTCCGCTTCACCAGCTCCAT 65°C BglI
CC-142, 103, 60
CG-163, 142, 103, 60
GG-163, 142
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n = 75 pHWE p
MMP1 rs1799750 1G/1G 21 22 0.05 0.794
1G/2G 26 29 0.986
2G/2G 20 24 0.782
2G 66 77 0.849
1G 68 73 0.849
MMP2 rs2285053 CC 51 60 0.233 0.576
CT 16 13 0.339
TT 0 2 0.526
 T 16 17 0.812
C 118 133 0.812
MMP2 rs243865 CC 7 1 0.000 0.044
CT 60 70 0.593
TT 0 4 0.162
T 60 78 0.428
C 74 72 0.428
MMP3 rs35068180 5A/5A 16 43 0.000 0.00005
5A/6A 34 15 0.0001
6A/6A 17 17 0.706
5A 66 101 0.002
6A 68 49 0.002
MMP9 rs3918242 CC 49 58 0.268 0.562
CT 14 17 0.799
TT 4 0 0.101
T 22 17 0.576
C 112 133 0.576
IL6 rs1800795 CC 17 22 0.662 0.597
CG 37 39 0.700
GG 13 14 0.911
G 63 67 0.743
C 71 83 0.743
TNF alpha rs1800629 GG 46 33 0.003 0.003
GA 20 41 0.003
AA 1 1 0.526
A 22 43 0.014
G 112 107 0.014
TGFB1 rs1800471 CC 56 65 0.536 0.779
CG 10 10 0.975
GG 1 0 0.954
G 12 10 0.494
C 122 140 0.494
For p value analysis, the chi2 or Yates’ corrected chi2 tests were used; HWE — Hardy–Weinberg equilibrium
444
Ginekologia Polska 2021, vol. 92, no. 6
www. journals.viamedica.pl/ginekologia_polska
gene is mainly regulated at the transcription level. The TNF 
gene polymorphism of greatest interest is the transition of 
the guanine into the adenine at the position of –308. This 
polymorphism identified as rs1800629 is associated with 
increased expression of TNF, probably by changing the 
binding efficiency of transcription factor AP 2 [25]. 
Among the three polymorphisms in cytokine genes 
investigated in this study, only TNF rs1800629 was found to 
be significantly associated with an increased risk of recur-
rent pregnancy loss. The analysis shows that patients with 
GG genotype for rs1800629 polymorphism have a higher 
risk of miscarriage according to controls (OR = 2.56, 95% 
CI: 1.23–5.32). 
A meta-analysis performed by a group from Iran showed 
a correlation of the rs1800629 polymorphism of the TNF gene 
promoter region with an increased risk of reproductive failure 
[6]. Moreover, it suggests that the investigated polymorphic 
variant is more significant in Asians than in Caucasians.
One of the purposes of this study was also to verify if 
the occurrence of five SNPs in the matrix metalloproteinase 
genes is related to the miscarriage predisposition.
Gelatinases A (MMP2) and B (MMP9) digests collagen 
type IV and V, elastin and other extracellular matrix proteins 
(ECM), which indicates their important role in the metabo-
lism of vessel basement membrane. 
MMP2 is encoded by the matrix metalloproteinase 
2 gene (MMP2) located on chromosome 16q12.2. Two poly-
morphic variants of this gene rs2285053 and rs243865 are 
located in the promoter region and are responsible for regu-
lating the expression of the MMP2 gene and thus may affect 
the amount of synthesized protein. The presence of thymi-
dine at positions –735 and –1306 in the MMP2 gene pro-
moter region prevents binding to the transcriptional factor 
Sp-1, thus reducing the activity of the MMP2 promoter [26].
We did not find an association between the studied 
polymorphism of MMP2 gene (rs2285053) and risk of re-
current pregnancy loss. These observations were similar 
to the results presented by Li et al., and. Behforouz et al. 
[19, 23]. However, not all studies are in consistency with 
results of the present study. Pereza et al., indicated that 
polymorphism rs2285053 was associated with recurrent 
miscarriage risk [27]. 
Results of our study referring to rs243865 MMP2 gene 
polymorphism after univariate analysis did not identify any 
significant relationship for genotype nor for allele distribu-
tion between cases and control. They agrees with the results 
of Behforouz et al. [23], Pereza et al. [27], and Ramu et al. 
[28]. In contrast Li et al. [19], showed that the polymorphism 
rs243865 were significantly associated with an increased 
susceptibility to recurrent miscarriages. 
Stromielizines, which include MMP3 (stromielizine-1), 
digest basement membrane collagen, proteoglycans and 
extracellular matrix glycoproteins. The stromielzine-1 gene 
is located on chromosome 11q22.3. The polymorphism 
rs35068180 of the MMP3 gene occurs at –1171 in the pro-
moter region and is associated with increased transcription 
and local expression of the MMP3 gene [29]. This common 
polymorphism, which was identified by Ye et al. [30], in 1996, 
has one allele with a sequence of six adenosine (6A) and an-
other five adenosine (5A). In vitro studies have shown that 
the 5A allele is associated with a higher expression of the 
MMP3 gene compared to the 6A allele [29, 30].
Our results show that the maternal polymorphism 
rs35068180 MMP3 gene occur significantly more frequently 
in RPL cases. Multifactorial analysis showed that patients 
with the 5A/5A genotype for the rs35068180 polymorphism 
of the MMP3 gene are about 0.24 less likely to experience 
a miscarriage OR (95% CI) = 0.24 (0.11–0.52). This relationship 
may result from the fact that 5A allele carriers, associated 
with higher transcriptional activity of MMP3 gene, are char-
acterized by higher degradation of the extracellular matrix. 
As a result, 5A allele predisposes to the successful of implan-
tation and consequently reduces the risk of pregnancy loss.
Our findings confirm the results of Behforouz et al. 
[23]. They have found a significant association between 
rs35068180 polymorphism of MMP3 gene and the preg-
nancy loss. The findings of this study are in keeping with 
the reports of Balci and Özdemir [31].
CONCLUSIONS
In the present study, we have for the first time inves-
tigated an association between recurrent pregnancy loss 
and the profile of eight selected single nucleotide polymor-
phisms in cytokine and metalloproteinase genes in women 
in the polish population.
In conclusion, this work has demonstrated an associa-
tion between TNF rs1800629 and MMP3 rs35068180 gene 
polymorphisms and recurrent pregnancy loss. Our results 
show that the maternal GG TNF and 5A/5A MMP3 gene geno-
types occur significantly more frequently in cases with re-
peated miscarriages. 
Limitations of the Study
The study included a relatively small number of pa-
tients, and the findings need to be confirmed in a larger 
population. 
Table 3. Logistic regression results determining the chance of 
a miscarriage
Parameter OR 95% Cl p
5A/5A MMP3 0.24 0.11 – 0.52 0.0002
GG TNF alpha 2.56 1.23 – 5.32 0.011
OR — odds ratio; CI — confidence interval
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